$100 Billion in SpaceX Shares Just Unlocked — So Why Isn’t the Stock Crashing?
SpaceX just had its biggest lockup expiration ever, flooding the market with enough newly eligible shares to unsettle even the most confident bull. What happened next surprised almost everyone watching.
For weeks, investors have focused on one date they believed could unleash another wave of selling in one of 2026’s most closely watched IPOs.
Lockup expirations often flood the market with new shares, increasing supply and weighing on stock prices, particularly when a company has already stumbled. SpaceX (NASDAQ:SPCX | SPCX Price Prediction) appeared to fit that script perfectly after a sharp post-earnings decline on Wednesday. Yet when roughly $100 billion worth of shares became eligible for sale today, the collapse many expected never materialized. Instead, the stock turned higher, offering investors an important reminder that what the market anticipates is often more important than what actually happens.
The Biggest Lockup Yet Didn’t Trigger the Expected Selling
SpaceX’s second-quarter earnings report on Tuesday showed the business continues executing well. Yet that wasn’t enough to stop shares from falling almost 15% on Wednesday as investors focused on another number entirely: capital spending. Like the hyperscalers pouring hundreds of billions of dollars into AI infrastructure, SpaceX’s growing investment bill raised fresh questions about future cash flow.
That earnings sell-off only added to concerns surrounding today’s lockup expiration. According to the SpaceX prospectus, the first lockup tranche becomes eligible for sale “on or after the second full trading day on Nasdaq immediately following” the release of second-quarter results. Because earnings were announced after the close on Aug. 4, today marked the first major unlock.
The numbers are eye-opening.
| Metric | Value |
| IPO price (June 2026) | $135 |
| Tradable shares before unlock | ~639 million |
| Shares eligible today | ~911.5 million |
| Estimated value at recent prices | ~$100 billion |
| Wednesday closing price | $108.27 |
On paper, more than doubling the tradable float should have created enormous selling pressure. Instead, by late morning Thursday, SpaceX is still up almost 3%% after gaining more than 5% earlier in the session.
Surprisingly, that’s exactly how many lockup expirations play out.
Eligible Doesn’t Mean Investors Rush to Sell
A lockup expiration makes shares eligible to trade. It doesn’t require insiders to sell them. Today’s newly eligible shareholders include employees and early investors who have held SpaceX for years. Even after the IPO, the stock remains roughly 20% below its $135 offering price and more than 50% below its post-IPO high near $226.
Many insiders may simply decide to wait. With a very low cost basis, they can afford to. Others remain restricted by extended lockups or Rule 10b5-1 trading plans that schedule sales over time rather than all at once.
Markets also tend to price in well-known risks before they happen. JPMorgan analyst Doug Anmuth noted investors had been positioning for this unlock for weeks, helping explain why much of the pressure may have already appeared during Wednesday’s earnings-driven decline.
At the same time, buyers stepped in. Retail investors were active purchasers following Wednesday’s drop, while Cathie Wood’s ARK Invest added more shares during the weakness. With reported short interest approaching 35% of the float, lighter-than-expected insider selling also created conditions for short covering that helped push shares higher.
Today’s Relief Rally Doesn’t Remove Tomorrow’s Risk
That said, investors shouldn’t conclude the overhang has disappeared. Today’s unlock represents only one step in SpaceX’s staggered release schedule. Another conditional tranche remains locked because the stock hasn’t met the required price threshold, while additional unlocks are scheduled throughout August, into October, and eventually through the primary 180-day lockup period ending in December. Elon Musk’s own stake remains locked until around June 2027.
Between now and the end of October, though, roughly $800 billion worth of additional SpaceX shares are expected to become eligible for trading under the company’s staggered lockup schedule. That creates an ongoing supply overhang even if today’s expiration passes without major disruption.
Again, not every newly eligible share will hit the market, but each new unlock represents another opportunity for supply to exceed demand if sentiment weakens.
Key Takeaway
In short, today’s trading action illustrates an important investing lesson: anticipated events often matter less than investor positioning going into them. The market already understood roughly $100 billion worth of SpaceX shares would become eligible today, and buyers proved willing to absorb that risk.
Regardless, the story isn’t over. SpaceX still faces rising capital expenditures, additional lockup expirations, and hundreds of billions of dollars in shares becoming eligible for sale over the next several months.
Long-term investors should pay less attention to a single day’s price movement than to whether demand continues matching that expanding supply. If it does, today’s feared collapse may become just another reminder that markets rarely follow the script everyone expects.
Contact [email protected] for any questions or corrections.
After two decades of patrolling the dark corners of suburbia as a police officer, Rich Duprey hung up his badge and gun to begin writing full time about stocks and investing. For the past 20 years he’s been cruising the markets looking for companies to lock up as long-term holdings in a portfolio while writing extensively on the broad sectors of consumer goods, technology, and industrials. Because his experience isn’t from the typical financial analyst track, Rich is able to break down complex topics into understandable and useful action points for the average investor. His writings have appeared on The Motley Fool, InvestorPlace, Yahoo! Finance, and Money Morning. He has been featured in both U.S. and international publications, including MarketWatch, Financial Times, Forbes, Fast Company, and USA Today.
